Skip to main content
Log in

Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer

  • Original Scientific Reports
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Neoadjuvant therapy for locally advanced breast cancer improves disease control, but the complications of treatment are not well established. The aim of this study was to assess the operative morbidity in 20 consecutive patients with locally advanced, noninflammatory breast cancer treated with preoperative chemotherapy and radiation. Patients received preoperative cyclophosphamide, methotrexate, 5-fluorouracil, prednisone, and tamoxifen (CMFPT) to maximum response followed by concurrent chemotherapy and radiation to the involved breast and regional lymph nodes. Following modified radical mastectomy, chemotherapy was continued for a total of 10 cycles. Disease progressed in 3 of 20 patients (15%). Seventeen patients underwent mastectomy, 4 (24%) of whom demonstrated a pathologic complete response to chemoradiotherapy. Seven patients (41%) developed wound infections, 2 (12%) necrosis, 5 (29%) delayed healing, 2 (12%) upper extremity lymphedema, and 8 (47%) seromas. Postoperative chemotherapy was delayed in 4 (24%) patients. There was no mortality, and hospitalization was for less than 1 week. Only one patient required readmission. Although this treatment regimen is aggressive with attendant morbidity, complications are easily managed and generally do not delay therapy. Treatment modification to further reduce complications may be indicated.

Résumé

La chimiothérapie néoadjuvante améliore l'état local du cancer du sein local avancé. Les complications de ce traitement, cependant, sont encore mal connues. Le but de cette étude a été d'évaluer la morbidité opératoire chez 20 patientes consécutives ayant un cancer du sein avancé, non inflammatoire, traitées par la chimiothérapie et irradiation préopératoires. Les patientes ont reçu une combinaison de cyclophospamide, méthotrexate, 5-fluorouracile, prédnisone et tamoxifène (CMFPT), jusqu'à obtention d'une réponse maximale, suivie de cette même chimiothérapie à dose stable et d'une irradiation du sein et des adénopathies régionales. Après une mastectomie radicale modifiée, la chimiothérapie a été continué pour un total de 10 cycles. Malgré ce, la maladie a continué d'évoluer chez trois des 20 patientes (15%). Dix-sept patientes ont eu une mastectomie, quatre (24%) parmi elles ayant eu une réponse complète anatomopathologique à la chimiothérapie. Sept patientes (41%) ont dévéloppé une infection pariétale, 2 (12%) une nécrose, 5 (29%) ont eu un retard de cicatrisation, 2 (12%), un lymphédème et 8 (47%), une collection séreuse. La chimiothérapie postopératoire a du être différée chez 4 (24%) patientes. Il n'y pas eu de mortalité et aucune patiente n'est restée à l'Hôpital plus d'une semaine. Une seule patiente a nécessité une réhospitalisation. En conclusion, cette modalité thérapeutique est aggressive et comporte une certaine morbidité. Néanmoins, les complications sont d'un traitement rélativement facile et en général, n'interfèrent pas avec la thérapeutique ultérieure. Il faut continuer à chercher à réduire cette morbidité.

Resumen

En tanto que la terapia neoadyuvante para el cáncer mamario localmente avanzado mejora el control de la enfermedad, las complicaciones del tratamiento no están aún bien establecidas. El propósito del presente estudio fue el de evaluar la mortalidad operatoria en 20 pacientes consecutivos con cáncer mamario localmente avanzado, no inflamatorio, tratado con un protocolo de de quimioterapia e irradiación preoperatoria.

Los pacientes recibieron ciclofosfamida preoperatoria, metotrexato, 5-fluoruracil, prednisona y tamoxifén (CMFPT) hasta el nível de maxima respuesta, seguido de quimioterapia y radioterapia concurrente al seno afectado y a los ganglios linfáticos regionales. Realizada la mastectomia radical modificada, se continuó la quimioterapia por un total de 10 ciclos.

La enfermedad continuó progresando en tres de 20 pacientes (15%). Diecisiete pacientes fueron sometidos a mastectomía, cuatro (24%) de los cuales demostraron remisión histopatológica completa a la quimiorradioterapia. Siete (41%) desarrollaron infección de la herida, 2 (12%) necrosis, 5 (29%) cicatrización retardada, 2 (12%) linfedema de la extremidad superior y 8 (47%) seroma. La quimioterapia postoperatoria fue demorada en 4 (24%) de los casos. No se registró mortalidad y no hubo hospitalizaciones de más de una semana. Solo un paciente requirió readmisió.

En conclusión, éste es un tratamiento agresivo que se acompaña de morbilidad. Sin embargo, las complicaciones son de fácil manejo y generalmente no demoran la terapia. Ciertas modificaciones del tratamiento orientadas a reducir aún más las complicaicones pueden estar indicadas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sondik, E.J., Young, J.L., Horm, J.W., Ries, L.A.G.: CDCPC 1985 Annual Cancer Statistics Review. NIH Publ. No. 86-2789. Bethesda, US Department of Health and Human Services, 1986

    Google Scholar 

  2. Zucali, R., Uslenghi, C., Kenda, R., Bonnadonna, G.: Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy. Cancer37:1422, 1976

    Google Scholar 

  3. Sorace, R.A., Lippman, M.E.: Locally advanced breast cancer. In Diagnosis and Management of Breast Cancer, M.E. Lippman, A. Lichte, D.N. Danforth, editors, Philadelphia, Saunders, 1988, pp. 272–295

    Google Scholar 

  4. Graham, M.V., Perez, C.A., Kuske, R.R., Garcia, D.M., Fineberg, B.: Locally advanced (noninflammatory) carcinoma of the breast: results and comparison of various treatment modalities. Int. J. Radiat. Oncol. Biol. Phys.21:311, 1991

    Google Scholar 

  5. Hortobagyi, G.N., Ames, F.C., Buzdar, A.U., Kau, S.W., McNeese, M.D., Paulers, D., Huy, V., Holmes, F.A., Romadahl, M.M., Fraschini, G., McBride, C.M., Martin, R.G., Montague, E.: Management of stage III breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer62:2507, 1988

    Google Scholar 

  6. Bland, K.I., Palin, W.E., von Fraunhofer, J.A., Morris, R.R., Adcock, R.A., Tobin, G.R.: Experimental and clinical observations of the effects of cytotoxic chemotherapeutic drugs on wound healing. Ann. Surg.199:782, 1984

    Google Scholar 

  7. Knight, C.D., Martin, J.K., Welch, J.S., Ingle, J.N., Gaffey, T.A., Martinez, A.: Surgical considerations after chemotherapy and radiation therapy for inflammatory carcinoma. Surgery99:385, 1986

    Google Scholar 

  8. El Din, A.B., Coibion, M., Guenier, C., Nogaret, J.M., Loreno, I., VanHoutte, P., Mattherim, W.: Local postoperative morbidity following pre-operative irradiation in locally advanced breast cancer. Eur. J. Surg. Oncol.15:486, 1989

    Google Scholar 

  9. Broadwater, J.R., Edwards, M.J., Kuglen, C., Hortobagyi, G.N., Ames, F.C., Balch, C.M.: Mastectomy following preoperative chemotherapy. Ann. Surg.213:126, 1991

    Google Scholar 

  10. Meakens, J.L.: Infection. In Care of the Surgical Patient, Vol. II. New York, Scientific American, 1988, pp. ix, 1, 5–7

    Google Scholar 

  11. Desprez, J.D., Kiehn, C.L.: The effects of Cytoxan (cyclophosphamide) on wound healing. Plast. Reconstr. Surg.26:301, 1960

    Google Scholar 

  12. Newcombe, J.F.: Effect of intra-arterial nitrogen mustard infusion on wound healing in rabbits: formation of granulation tissue and wound contraction. Ann. Surg.163:319, 1966

    Google Scholar 

  13. Cohen, S.C., Gabelnick, H.L., Johnson, R.K., Goldin, A.: Effects of antineoplastic agents on wound healing in mice. Surgery78:238, 1975

    Google Scholar 

  14. Devereux, D.F., Thibault, L., Boretos, J., Brennan, M.F.: The quantitative and qualitative impairment of wound healing by Adriamycin. Cancer43:932, 1979

    Google Scholar 

  15. Calnan, J., Davies, A.: The effect of methotrexate (amethopterin) on wound healing; an experimental study. Br. J. Cancer19:505, 1965

    Google Scholar 

  16. Goldman, L., Lowe, S., Al-Saleem, T.: Effect of fluorouracil on intestinal anastomoses in the rat. Arch. Surg.98:303, 1969

    Google Scholar 

  17. Finn, D., Steele, G., Jr., Osteen, R.T., Wilson, R.E.: Morbidity and mortality after surgery in patients with disseminated or locally advanced cancer receiving systemic chemotherapy. J. Surg. Oncol.13:237, 1980

    Google Scholar 

  18. Finney, R.: Adjuvant chemotherapy in the radical treatment of carcinoma of the breast—a clinical trial. Am. J. Roentgenol. Radium Ther. Nucl. Med.111:137, 1971

    Google Scholar 

  19. Higgins, G.A., Dwight, R.W., Smith, J.V., Keehn, R.J.: Fluorouracil as an adjuvant to surgery in carcinoma of the colon. Arch. Surg.102:339, 1971

    Google Scholar 

  20. Karrar, K.: Importance of dosage schedules in adjuvant chemotherapy. Cancer Chemother. Rep.56:35, 1972

    Google Scholar 

  21. Ferguson, M.K.: The effect of antineoplastic agents on wound healing. Surg. Gynecol. Obstet.154:421, 1982

    Google Scholar 

  22. Rubin, P., Casarett, G.W.: In Clinical Radiation Pathology, Vols. I and II. Philadelphia, Saunders, 1984

    Google Scholar 

  23. Montague, E.D.: Experience with altered fractionation in radiation therapy of breast cancer. Radiology90:962, 1968

    Google Scholar 

  24. Fowble, B., Glover, D., Rosato, E.F., Goodman, R.L.: Combined modality treatment of inflammatory breast cancer. Int. J. Radiat. Oncol. Biol. Phys.12(Suppl. I):151, 1986

    Google Scholar 

  25. Leis, H.P.: Selective moderate surgical approach for potentially curable breast cancer. In The Breast, H.S. Gallagher, H.P. Leis, R.K. Snyderman, J.A. Urban, editors, St. Louis, Mosby, 1978, p. 232

    Google Scholar 

  26. Hayward, J.L., Winter, P.J., Tong, D., Rubens, R.D., Payne, J.G., Chaudary, M.A., Habibollahi, F.: A new approach to the conservative treatment of early breast cancer. Surgery95:270, 1984

    Google Scholar 

  27. Say, C.C., Donegan, W.L.: A biostatistical evaluation of complications from mastectomy. Surg. Gynecol. Obstet.138:370, 1974

    Google Scholar 

  28. Piccart, M.J., deValeriola, D., Paridaens, R.: Six-year results of a multimodality treatment strategy for locally advanced breast cancer. Cancer62:2501, 1988

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sauter, E.R., Eisenberg, B.L., Hoffman, J.P. et al. Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer. World J. Surg. 17, 237–241 (1993). https://doi.org/10.1007/BF01658934

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01658934

Keywords

Navigation